We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-1.36%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.32B
AUM Growth
-$280M
Cap. Flow
-$198M
Cap. Flow %
-15.04%
Top 10 Hldgs %
17.04%
Holding
1,626
New
448
Increased
346
Reduced
313
Closed
483

Sector Composition

Rank Sector Weight
1 Technology 13.2%
2 Healthcare 10.48%
3 Consumer Discretionary 9.93%
4 Financials 7.26%
5 Communication Services 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
351
JPMorgan Chase
JPM
$956B
$849K 0.06%
3,461
-847
-20% -$216K
PSLV icon
352
Sprott Physical Silver Trust
PSLV
$13.7B
$843K 0.06%
72,703
+52,310
+257% +$565K
PRTH icon
353
Priority Technology Holdings
PRTH
$431M
$843K 0.06%
+123,733
New +$1.17M
AAPL icon
354
Apple
AAPL
$4.5T
$843K 0.06%
3,793
-5,332
-58% -$1.24M
RHP icon
355
Ryman Hospitality Properties
RHP
$7.57B
$819K 0.06%
8,960
-7,393
-45% -$742K
FRO icon
356
Frontline
FRO
$8.56B
$819K 0.06%
55,157
+42,907
+350% +$709K
AXP icon
357
American Express
AXP
$229B
$816K 0.06%
3,033
+1,138
+60% +$336K
RCL icon
358
Royal Caribbean
RCL
$82.4B
$807K 0.06%
3,929
+2,557
+186% +$604K
DADA
359
DELISTED
Dada Nexus
DADA
$806K 0.06%
+435,932
New +$750K
REPL icon
360
Replimune Group
REPL
$1.15B
$805K 0.06%
82,562
+66,244
+406% +$820K
RGNX icon
361
Regenxbio
RGNX
$688M
$805K 0.06%
+112,520
New +$837K
RPRX icon
362
Royalty Pharma
RPRX
$25.8B
$804K 0.06%
+25,841
New +$819K
P
363
Everpure Inc
P
$32.6B
$802K 0.06%
18,114
-12,692
-41% -$766K
OSPN icon
364
OneSpan
OSPN
$603M
$802K 0.06%
52,566
+5,589
+12% +$99.5K
VEEV icon
365
Veeva Systems
VEEV
$38.1B
$795K 0.06%
3,434
+2,151
+168% +$492K
EGP icon
366
EastGroup Properties
EGP
$10.9B
$793K 0.06%
4,500
-3,077
-41% -$535K
ELME
367
Elme Communities
ELME
$144M
$789K 0.06%
+45,321
New +$731K
GDS icon
368
GDS Holdings
GDS
$6.29B
$785K 0.06%
31,003
+6,103
+25% +$185K
AMKR icon
369
CALL
Amkor Technology
AMKR
$13.1B
$784K 0.06%
+43,400
New +$980K
ACI icon
370
Albertsons Companies
ACI
$5.89B
$783K 0.06%
35,623
-29,909
-46% -$617K
BSX icon
371
Boston Scientific
BSX
$73.1B
$780K 0.06%
7,731
-5,060
-40% -$510K
BKNG icon
372
Booking.com
BKNG
$160B
$769K 0.06%
4,175
+425
+11% +$81.3K
AMED
373
CALL
DELISTED
Amedisys
AMED
$769K 0.06%
+8,300
New +$765K
XPRO icon
374
Expro Ltd
XPRO
$2.01B
$766K 0.06%
77,101
+28,137
+57% +$347K
WSR
375
DELISTED
Whitestone REIT
WSR
$764K 0.06%
52,426
+900
+2% +$12.4K

Similar funds

Prelude Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Prelude Capital Management held 1,626 positions worth $1.32B, down 18% from $1.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Prelude Capital Management withdrew a net $198M in Q1 2025, closing 483 positions and reducing 313 holdings. Its most notable exit was Smartsheet Inc., an estimated $14M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Intra-Cellular Therapies Inc. worth $10.4M.

  • Prelude Capital Management's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 79,142 shares worth $10.4M.
  • Prelude Capital Management added most to Alphabet (Google) Class A in Q1 2025, an estimated $9.7M increase.
  • Prelude Capital Management's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $9.36M.
  • Prelude Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $14M.
  • Prelude Capital Management's ten largest holdings make up 17% of its $1.32B portfolio in Q1 2025.
  • Prelude Capital Management opened 448 new positions and closed 483 in Q1 2025.
  • Prelude Capital Management's portfolio value fell 18% quarter-over-quarter to $1.32B.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.